Zhang J, Chen L, Han L, Shi Z, Zhang J, Pu P, Kang C. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma. Cancer Lett. 2015 Jan 28;356(2 Pt B):929-36. doi: 10.1016/j.canlet.2014.11.003. Epub 2014 Nov 11. PubMed PMID: 25444902.
Pont LM, Naipal K, Kloezeman JJ, Venkatesan S, van den Bent M, van Gent DC, Dirven CM, Kanaar R, Lamfers ML, Leenstra S. DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells. Cancer Lett. 2015 Jan
28;356(2 Pt B):525-35. doi: 10.1016/j.canlet.2014.09.049. Epub 2014 Oct 8. PubMed PMID: 25305451.
Renjie W, Haiqian L. MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5. Cancer Lett. 2015 Jan 28;356(2 Pt B):568-78. doi: 10.1016/j.canlet.2014.10.003. Epub 2014 Oct 8. PubMed PMID: 25305447.
Huang S, Wang C, Yi Y, Sun X, Luo M, Zhou Z, Li J, Cai Y, Jiang X, Ke Y.
Krüppel-like factor 9 inhibits glioma cell proliferation and tumorigenicity via downregulation of miR-21. Cancer Lett. 2015 Jan 28;356(2 Pt B):547-55. doi: 10.1016/j.canlet.2014.10.007. Epub 2014 Oct 8. PubMed PMID: 25305446.
Hara K, Kageji T, Mizobuchi Y, Kitazato KT, Okazaki T, Fujihara T, Nakajima K, Mure H, Kuwayama K, Hara T, Nagahiro S. Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma. Cancer Lett. 2015 Jan 28;356(2 Pt B):496-505. doi: 10.1016/j.canlet.2014.09.045. Epub 2014 Oct 6. PubMed PMID:
25301448.